Le Berre C, Honap S, Peyrin-Biroulet L. Ulcerative colitis. Lancet. 2023;402:571–84.
Watanabe T, Minaga K, Kamata K, et al. RICK/RIP2 is a NOD2-independent nodal point of gut inflammation. Int Immunol. 2019;31:669–83.
Article CAS PubMed PubMed Central Google Scholar
Masuta Y, Minaga K, Kurimoto M, et al. Activation of nucleotide-binding oligomerization domain 2 by muramyl dipeptide negatively regulates toll-like receptor 9-mediated colonic inflammation through the induction of deubiquitinating enzyme a expression. Int Immunol. 2023;35:79–94.
Article CAS PubMed Google Scholar
Hori K, Ikeuchi H, Nakano H, et al. Gastroduodenitis associated with ulcerative colitis. J Gastroenterol. 2008;43:193–201.
Sun Y, Zhang Z, Zheng CQ, et al. Mucosal lesions of the upper gastrointestinal tract in patients with ulcerative colitis: a review. World J Gastroenterol. 2021;27:2963–78.
Article CAS PubMed PubMed Central Google Scholar
Schett G, McInnes IB, Neurath MF. Reframing immune-mediated inflammatory diseases through signature cytokine hubs. N Engl J Med. 2021;385:628–39.
Article CAS PubMed Google Scholar
Masaki S, Watanabe T, Arai Y, et al. Expression levels of cellular inhibitor of apoptosis proteins and colitogenic cytokines are inversely correlated with the activation of interferon regulatory factor 4. Clin Exp Immunol. 2022;207:340–50.
Article PubMed PubMed Central Google Scholar
Hisabe T, Matsui T, Miyaoka M, et al. Diagnosis and clinical course of ulcerative gastroduodenal lesion associated with ulcerative colitis: possible relationship with pouchitis. Dig Endosc. 2010;22:268–74.
Li M, Liu Y, Cui J, et al. Ulcerative colitis with mucosal lesions in duodenum: two case reports. Medicine (Baltimore). 2019;98: e15035.
Valdez R, Appelman HD, Bronner MP, et al. Diffuse duodenitis associated with ulcerative colitis. Am J Surg Pathol. 2000;24:1407–13.
Article CAS PubMed Google Scholar
Hayashi T, Terashima T, Nishitani M, et al. Gastroduodenitis Associated with active ulcerative colitis treated with infliximab: different clinical course in the colon and gastroduodenal lesions. Intern Med. 2024;63:929–35.
Chiba M, Ono I, Wakamatsu H, et al. Diffuse gastroduodenitis associated with ulcerative colitis: treatment by infliximab. Dig Endosc. 2013;25:622–5.
Akitake R, Nakase H, Tamaoki M, et al. Modulation of Th1/Th2 balance by infliximab rescues postoperative occurrence of small-intestinal inflammation associated with ulcerative colitis. Dig Dis Sci. 2010;55:1781–4.
Choi YS, Kim JK, Kim WJ, et al. Remission of diffuse ulcerative duodenitis in a patient with ulcerative colitis after infliximab therapy: a case study and review of the literature. Intest Res. 2019;17:273–7.
Article PubMed PubMed Central Google Scholar
Willington AJ, Taylor G, White J, et al. Gastrointestinal: ulcerative colitis-associated duodenitis. J Gastroenterol Hepatol. 2018;33:973.
Article CAS PubMed Google Scholar
Neurath MF. Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014;14:329–42.
留言 (0)